Individualized treatment. Regimen design for the problem Type Ii diabetic
Johnson, B.E.; Kyner, J.L.; Bolinger, R.E.
Journal of the Kansas Medical Society 84(3): 103-108; 161
1983
ISSN/ISBN: 0022-8699 PMID: 6341489 Document Number: 210712
Document emailed within 1 workday
Related Documents
Nanni, J.M.; Nguyen, K.H.; Alford, C.E.; Robinson, C.P.; Stewart, C.M.; Maeda, N.; Humphreys-Beher, M.G. 1997: Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse Clinical and Experimental Rheumatology 15(5): 515-521Gambaro, G.; Morbiato, F.; Cicerello, E.; Del Turco, M.; Sartori, L.; D'Angelo, A.; Crepaldi, G. 1985: Captopril in the treatment of hypertension in type i and type Ii diabetic patients Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(2): S149-S151
Ritschel, W.A.; Brady, M.E. 1979: Animal model for pharmacokinetic approach to individualized heparin dosage regimen for I.v. infusion by constant rate to achieve and maintain a desired clotting time Arzneimittel-Forschung 29(12): 1891-1894
Bu, S.; Guo, X.-H.; Yang, W.-Y.; Lu, G.-Z.; Yang, Z.-J.; Ren, T.-T.; Gao, Y. 2007: Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen Zhonghua Yi Xue Za Zhi 87(44): 3115-3118
Liu, H.; Weng, Y.; Zhang, Y.; Xu, N.; Tong, J.; Wang, C. 2015: Computer Assisted Design and Electron Beammelting Rapid Prototyping Metal Three-Dimensional Printing Technology for Preparation of Individualized Femoral Prosthesis Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 29(9): 1088-1091
Paster, R.Z.; McAdoo, M.A.; Keyserling, C.H.; Nemeth, M.A.; Tack, K.J.; Griffin, T.J. 2000: A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis International Journal of Clinical Practice 54(5): 293-299
DeVane, C.L.; Gill, H.S. 1997: Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design Journal of Clinical Psychiatry 58(Suppl): 7-14
L.P.ole, C.; Weijmer, M.; Van Ittersum, F.; Valentijn, R.; Ter Wee, P. 2002: Outcome of routine laboratory data after 30 weeks of treatment with a PD regimen low in glucose and GDPs or a standard PD regimen in newly CAPD patients Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 200A
Knight, K.M.; Thornburg, L.L.; Pressman, E.K. 2012: Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiabetic controls Journal of Reproductive Medicine 57(9-10): 397-404
Stiefelhagen, P. 2010: Type-2 diabetics need individualized diet advice. No evidence for culinary sadism MMW Fortschritte der Medizin 152(31-33): 15
Chantrel, F.; Bouiller, M.; Kolb, I.; Hannedouche, T. 2000: Antihypertensive treatment in type II diabetes and diabetic nephropathy Nephrologie 21(2): 47-55
Drivsholm, T.B.; Snorgaard, O. 2012: Organization of treatment and control of type 2 diabetic patients Ugeskrift for Laeger 174(37): 2159-2162
Gin, H.; Perlemoine, C.; Raffaitin, C.; Rigalleau, V. 2006: Treatment of type Ii diabetic patients with chronic renal failure Nephrologie and Therapeutique 2(Suppl 1): S59-S62
Páv, J. 1984: The diabetic regimen in the light of new findings in the therapy of diabetes Casopis Lekaru Ceskych 123(26): 790-793
Niskanen, L.K.; Uusitupa, M.I.; Pyörälä, K. 1991: The relationship of hyperinsulinaemia to the development of hypertension in type 2 diabetic patients and in non-diabetic subjects Journal of Human Hypertension 5(3): 155-159
Alebiosu, C.Olutayo.; Odusan, O.; Jaiyesimi, A. 2003: Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients Journal of the National Medical Association 95(11): 1042-1047
Meyer-Schwickerath, E.; Scheider, A.; Thurau, S.R.; Ulbig, M.; Landgraf, R.; Kampik, A.; Land, W. 1993: Does combined pancreas-kidney transplantation modify diabetic retinopathy in type-1 diabetic patients? Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 90(3): 283-288
Zhou, Y.; Guo, L.-x.; Yu, D.-n.; Zhou, L.; Wang, Y.; Mou, Z.-q.; Wang, X.-x.; Zhang, L.-n.; Li, M. 2012: Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 610-613
Hajra, B.; Orakzai, B.A.; Faryal, U.; Hassan, M.; Rasheed, S.; Wazir, S. 2016: Insulin Sensitivity to Trace Metals (Chromium, Manganese) in Type 2 Diabetic Patients and Non Diabetic Individuals Journal of Ayub Medical College Abbottabad: Jamc 28(3): 534-536
Tomić, N.G.; Marusić, S.ćk.; Bozikov, V.; Kusec, R.; Bacić-Vrca, V.; Tadić, M. 2013: The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients Collegium Antropologicum 37(3): 789-793